Category: Press Releases

German GKV-Spitzenverband to Provide Exoskeleton Devices for all Qualifying Beneficiaries in Landmark National Policy Decision MARLBOROUGH, MA / BERLIN, GERMANY// February 1, 2018 // GKV-Spitzenverband, the head office of German statutory health insurance (SHI), confirmed their decision to list the ReWalk (Nasdaq: RWLK) Personal 6.0 Exoskeleton System in the German Medical Device Directory (MDD, Hilfsmittelverzeichnis), […]

MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL—November 30, 2017– ReWalk Robotics’ innovative Restore soft exoskeleton system was featured in a recent story as one of the cutting edge technologies seeking to help stroke survivors heal and retain critical motor skills.  The story published in Medical Device & Diagnostic Industry (MD&DI), a leading industry trade magazine. The […]

Exoskeleton technology demonstrated for Heads of State as part of Israeli state visit to Spain MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL / BERLIN, GERMANY—November 22, 2017 – A team from ReWalk Robotics accompanied an Israeli state visit to Spain and presented ReWalk’s leading exoskeleton technology to Spain’s Heads of State in Madrid.  ReWalker Marcela Turnage […]

         The ReWalk Robotics family lost a remarkable, highly-esteemed and devoted member of our team. Jodi Gricci, ReWalk’s Chief Commercial Officer, passed away on October 18th at the age of 49, after years of struggling with cancer.           With her close relationships and focus on our customers, Jodi was […]

ReWalk Robotics & Harvard’s Wyss Institute Are Collaborating on Design for Soft Exosuit for Stroke Survivors YOKNEAM ILIT, Israel and MARLBOROUGH, MA – October 16, 2017 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”) today announced that the soft exosuit technology currently in development has entered the next phase of testing and verification in collaboration with researchers […]

Studies to focus on use with stroke patients MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL — October 16, 2017 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”) announced today completion of all internal processes to initiate clinical studies and the initial production of its “soft suit” exoskeleton design for stroke patients. Called “Restore,” the new system is the […]

Study Examines Use of Restore™ System Developed by Harvard’s Wyss Institute MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL—August 2, 2017 – A new study published in the Journal of Science Translational Medicine finds that use of a soft suit exoskeleton system facilitates normal walking ability for ambulatory patients following a stroke. The paper, which is authored […]

Exclusive Agreement with One of France’s Largest Medical Device Providers To Facilitate Distribution of ReWalk Systems to the Spinal Cord Injured Community MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL—July 11, 2017 — ReWalk Robotics Ltd. (NASDAQ: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of exoskeleton systems, announced today that the Company has signed a new, […]

“Restore” NextGen Exoskeleton System Developed in Collaboration with Harvard’s Wyss Institute MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL – June 19, 2017 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), leading manufacturer of exoskeleton systems, premiered the prototype for a soft suit exoskeleton intended to assist stroke survivors on Yahoo Finance. ReWalk CEO Larry Jasinski was joined […]

Ruling Cites Wealth of Evidence, Data to Confirm Exoskeleton Technology No Longer Experimental MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL – June 12, 2017 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), leading manufacturer of exoskeleton systems, today announced a Florida court ruling that found Blue Cross Blue Shield of Florida must provide coverage of a ReWalk exoskeleton […]

Leading Exoskeleton Manufacturer Promotes Gricci, Expands Leadership Team MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL, – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), leading manufacturer of exoskeleton systems, today announced the appointment of Jodi Gricci to the role of Chief Commercial Officer. Ms. Gricci previously served as Vice President, Global Marketing, Training, and Service while ReWalk established […]

VA Begins Second Year of National Study of ReWalk Robotics Exoskeleton for Personal Use YOKNEAM ILIT, ISRAEL / MARLBOROUGH, MA, April 6, 2017 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), leading manufacturer and producer of exoskeleton systems, announced today that the U.S. Department of Veterans Affairs (VA) purchased 28 ReWalk Personal Exoskeleton Systems to support […]

Leading Exoskeleton Manufacturer to Herald New Wave of Israeli Innovation YOKNEAM ILIT, Israel and MARLBOROUGH, MA – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), the leading global exoskeleton developer and manufacturer, today announced that CEO Larry Jasinski will join Danny Danon, Israeli Ambassador to the U.N., and more than one hundred U.N. and diplomatic staff in celebrating Israel’s thriving entrepreneurial ecosystem. […]

Retired West Midlands Police Officer Uses ReWalk System to Participate in the 1st Annual Parallel UK Race LONDON, England & YOKNEAM, Israel – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), the leading global exoskeleton developer and manufacturer, today announced the donation of a ReWalk Personal 6.0 System to Nicki Donnelly, a retired West Midlands Police Officer in the […]

Leading Exoskeleton Manufacturer Establishes Global Footprint Across North America, EU, Asia & Pacific YOKNEAM ILIT, Israel and MARLBOROUGH, MA – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), the leading global exoskeleton developer and manufacturer, today announced that the Company sold its 100th personal system this summer, a major milestone indicating growing adoption of personal use of exoskeletons.  The […]

Social Welfare Court Decision in Germany:  Reimbursement Approved on Appeal August 4, 2016—ReWalk Robotics (NASDAQ: RWLK), the leading developer and manufacturer of exoskeletons, announced the first ruling by the Social Welfare Court of Speyer declaring the ReWalk exoskeleton system was medically necessary and should be covered by insurance for an individual with spinal cord injury […]

Oracle Contracted for Electronic Data Capture System to Manage Study Data August 2, 2016 – Leading exoskeleton manufacturer and developer ReWalk Robotics (NASDAQ: RWLK) announced the initiation of its U.S. Food and Drug Administration (FDA) Section 522 post-market study with the Stanford University School of Medicine listed as the lead study center.  Dr. Matthew Smuck, […]

Five-Year Agreement Establishes Unique Collaboration and Extensive IP Licensing for “Soft Suit” Exoskeleton Systems YOKNEAM ILIT, Israel and MARLBOROUGH, MA — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “Company”), the leading global exoskeleton developer and manufacturer today announced a collaboration with Harvard University’s Wyss Institute for Biologically Inspired Engineering for the licensing of Intellectual Property (IP), and […]

–First Rewalk Device Reimbursed as Part of Comprehensive Policy Issued by Commercial Insurer– YOKNEAM ILIT, Israel and MARLBOROUGH, MA – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), the leading global exoskeleton developer and manufacturer, announced today that a commercial health insurance plan has implemented a medical policy stating that powered exoskeletons for ambulation in patients with lower […]

Growth driven by U.S. Veterans Administration and Commercial Insurance Reimbursement YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., May 05, 2016 (GLOBE NEWSWIRE) – ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three-month period ended March 31, 2016. Highlights of and subsequent to the first quarter include: Total revenue for the […]